When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says

[ad_1]


The Serum Institute of India said, “Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials.”

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Polynion

Binance Prediction

Metamask

papamiaspizza.com

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99